Erez Chimovits
Executive Director
pharmaceutical
BiomX
Israel
Biography
Erez Chimovits is a senior managing director at Orbimed Healthcare Fund Management. Mr. Chimovits has 14 years of operational experience, including 10 years of senior managerial experience in public companies. Prior to joining OrbiMed, Mr. Chimovits was the CEO of NasVax (TASE:NSVX), which acquired Protea and struck agreements with GlaxoSmithKline and Novartis. Previously, Mr. Chimovits spent more than seven years with Compugen (Nasdaq:CGEN), as president of Compugen USA Inc., and as executive vice president of commercial operations. At Compugen, he had P&L responsibility for more than 100 people and led multiple transactions with companies including J&J, Novartis, Teva, Abbott, and Medarex. Mr. Chimovits earned his M.B.A., M.Sc. in Microbiology, and B.Sc. from Tel Aviv University.
Research Interest
Pharmaceutical science
